VMR uses time-series analysis, S-curve adoption modeling, regression forecasting, and best/base/worst case scenario modeling, combined with bottom-up and top-down sizing across geographies and segments
Current UK regulatory position includes: Warnings and precautions regarding thyroid C-cell tumours based on animal data, with acknowledgement that human relevance is uncertain Advice regarding pancreatitis risk, with recommendations to discontinue if acute pancreatitis is suspected and not to restart if confirmed No restrictions based on general cancer risk, as human evidence does not support an increased overall malignancy risk Monitoring for gallbladder disease, which has been associated with GLP-1 receptor agonist use The Summary of Product Characteristics (SmPC) for each GLP-1 medicine includes detailed safety information that healthcare professionals should review before prescribing
Eating foods high in L-glutamine (spinach, cabbage, eggs), taking magnesium and B-complex supplements, drinking herbal teas such as chamomile or valerian at times you would normally drink, regular aerobic exercise, and cold water exposure have all shown benefit
Compared with NNT 3P-MACE (based on the primary CV composite endpoint), the addition of all-cause hospitalization (ACH) in the time to first-event analysis reduces the counts of other fatal and non-fatal events, suggesting ACH is a precursor to more severe events
avoid excessive iodine supplements and seaweed products Concerns about goitrogenic foods (raw cruciferous vegetables) are generally not clinically significant in iodine-replete settings with normal thyroid function or well-controlled hypothyroidism
